Phytochemical investigation of the roots of Astragalus spinosus Forssk (Fabaceae) resulted in the isolation of ten metabolites. The structure of spinocoumarin I (1), a new coumarin derivative, was established as 3-[(cis-2',5'-dihydroxycinnamoyl)]-7-hydroxy-6-methoxycoumarin. The structures of the isolated compounds were determined using spectroscopic methods. All compounds exhibited weak antiproliferative activity against the A2780 ovarian cancer cell line.
Astragalus L. is the largest genus in the family Fabaceae, and is represented by thirty-two species in Egypt [1, 2] . Some species of this genus have been reported to have immunostimulant, cardiovascular and antiviral activities [3, 4] . Previous phytochemical studies performed on some Egyptian Astragalus species, including A. spinosus Forssk., have resulted in the isolation of a series of cycloartane-type saponins [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . In our efforts to carry out a chemical investigation of various Egyptian Astragalus species, a study of A. spinosus roots, as well as evaluation of the antiproliferative activity of the isolates against the A2780 ovarian cancer cell line were preformed. The present paper describes the isolation and structure elucidation of a new coumarin derivative, spinocoumarin I (1), along with nine known compounds from the roots of A. spinosus. These include five cycloartane-type glycosides, astrasieversianin VI (6) [15] , astragalloside I (7) [13] , astrasieversianin II (8) [15] , trigonoside III (9) [8] and trigonoside II (10) [8] , one cycloartane-type glycone, cycloastragenol (3) [16] , one isoflavone, formononetin (2) [17] , and two sterols, stigmasterol (4) and stigmasterol-3-O-glucoside (5). The known compounds were identified by comparison of their spectroscopic data with literature data. Spinocoumarin I (1) was isolated as pale yellow needles with mp 249 o C. The HR-FABMS of 1 displayed a pseudomolecular ion peak at m/z 371.07673 [M+H] + , indicating the molecular formula C 19 H 14 O 8 . The UV spectrum of 1 showed absorption maxima at 342, 288 and 251 (sh) nm in CH 3 OH and the compound gave a blue fluorescence under UVlight, which changed to greenish blue with ammonia vapor, suggesting the presence of a coumarin skeleton [18, 19] . The IR spectrum had an absorption band at 1691 cm -1 , typical of the lactone carbonyl group of a coumarin [18] . The 1 H NMR spectrum of 1 showed three singlets at δ H 7.80, 7.22, and 6.88, corresponding to carbons at δ C 131.2, 109.6, and 103.5, respectively in the HSQC spectrum, suggesting a 3,6,7-trisubstituted coumarin skeleton (Table 1 ). Additionally, the 1 H NMR spectrum revealed a methoxy signal at δ H 3.90. The location of this methoxy group was assigned at C-6 due to its NOESY correlation with H-5 at δ H 7.22. 13 C NMR spectra of 1 showed the presence of a 2',5'-dihydroxycinnamoyl moiety assigned to C-3 {δ H 6.38, 1H, d, J = 9.2 Hz (H-α); 7.04, 1H, d, J = 2.4 Hz (H-6'); 7.09, 1H, dd, J = 8.8, 2.4 Hz (H-4'); 7.66, 1H, d, J = 8.8 Hz (H-3'); and 7.94, 1H, d, J = 9.2 Hz (H-β), and δ C 131.1 (C-1'), 144.1 (C-2'), 130.3 (C-3'), 104.7 (C-4'), 156.3 (C-5'), 114.1 (C-6'), 144.1 (C-β), 114.8 (C-α), and 160.9 (C-9')} [20] (Table 1 ). The presence of the 2',5'-dihydroxycinnamoyl moiety was confirmed by HMBC correlations (H-α/C-9'; H-3'/C-1', C-5', C-2'; H-β/C-1', C-6', C-5', C-9'), and further supported by EIMS analysis, which showed a characteristic fragment at m/z 179 (C 9 H 7 O 4 ). The cis configuration of the cinnamoyl moiety was determined by the coupling constant between H-α and H-β (J <11 Hz) [21] and was supported by their NOESY correlation. This structure was also confirmed by COSY (H-α/H-β; H-3'/H-4') correlations. The structure of 1 was, therefore, deduced as 3-[cis-(2',5'-dihydroxycinnamoyl)]-7-hydroxy-6-methoxycoumarin, and was given the trivial name name spinocoumarin I. The known metabolites, 2-10 have not been isolated previously from A. spinosus roots, but 7 has been isolated from the aerial parts of this plant [13] . All the isolates (1-10) exhibited weak antiproliferative activity against the A2780 ovarian cancer cell line (Table 2) . Crude extract (100 g) was dissolved in CH 3 OH:H 2 O (1:1, 500 mL) and extracted successively with n-hexane (500 mL x 3), CH 2 Cl 2 (500 mL x 4) and n-butanol (500 mL x 2). The n-hexane-soluble extract (3.0 g) yielded 4 (75 mg) upon crystallization from EtOAc. The CH 2 Cl 2 soluble extract (13.6 g) was chromatographed on a Si gel column (400 g, 4 cm in diameter) using CH 2 Cl 2 :CH 3 OH (10:0 to 8:2). Twenty-nine fractions (1-29) of 50 mL each were collected. Fractions 1-9 (360 mg) were dissolved in CH 3 OH and left overnight to form yellow needles of 1 (12 mg) and a clear supernatant. The supernatant was dried (348 mg) and subjected to PTLC on Si gel using CH 2 Cl 2 :CH 3 OH (19:1) as mobile phase, followed by C18 HPLC using CH 3 OH: H 2 O (6:4) as mobile phase to afford 2 (2.1 mg, R t = 4.4 min, column size = 250 x 10 mm, flow rate 2 mL/min).
Fractions 12-16 (530 mg) were chromatographed on a Si gel column (100 g, 2 cm in diameter) eluted with n-hexane: EtOAc (7:3), followed by Si gel PTLC using CH 2 The n-butanol soluble extract (1.2 g) was fractionated by column chromatography on MCI gel (50 g, 2 cm in diameter) using CH 3 OH: H 2 O (1:1 to 10:0). Sixteen fractions (1-16) were collected. Fractions 11-15 (91 mg) were further separated by C18 flash column chromatography, eluting with CH 3 CN: H 2 O (6:4 to 10:0) to yield eleven fractions (11-15-a to 11-15-k). Fraction 11-15-c (33 mg) was subjected to column chromatography over Si gel using CH 3 OH: EtOAc (9:1) to afford 9 (13 mg) and 10 (3.2 mg).
Bioassay: Compounds 1-10 were evaluated in the A2780 antiproliferative assay, as previously described [21] . All the compounds showed weak activity; the results are presented in (Table 2) . 
